384
Views
9
CrossRef citations to date
0
Altmetric
Studies in Humans

Long-term kinetics of daidzein and its main metabolites in human equol-producers after soymilk intake: identification of equol-conjugates by UPLC-orbitrap-MS and influence of the number of transforming bacteria on plasma kinetics

&
Pages 496-506 | Received 31 Aug 2016, Accepted 29 Oct 2016, Published online: 16 Nov 2016

References

  • Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 333:276–282.
  • Bayer T, Colnot T, Wolfgang Dekant W. 2001. Disposition and biotransformation of the estrogenic isoflavone daidzein in rats. Toxicol Sci. 62:205–211.
  • Bosland MC, Kato I, Zeleniuch-Jacquotte A, Schmoll J, Enk Rueter E, Melamed J, Kong MX, Macias V, Kajdacsy-Balla A, Lumey LH, et al. 2013. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA. 310:170–178.
  • Chang Y, Choue R. 2013. Plasma pharmacokinetics and urinary excretion of isoflavones after ingestion of soy products with different aglycone/glucoside ratios in South Korean women. Nutr Res Pract. 7:393–399.
  • Clarke DB, Lloyd AS, Botting NP, Oldfield MF, Needs PW, Wiseman H. 2002. Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with [13C3] isoflavone internal standards. Anal Biochem. 309:158–172.
  • Coxam V. 2008. Phyto-oestrogens and bone health. Proc Nutr Soc. 67:185–195.
  • Doerge DR, Chang HC, Churchwell MI, Holder CL. 2000. Analysis of soy isoflavones conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos. 28:298–307.
  • Euhara M. 2013. Isoflavone metabolism and bone-sparing effects of daidzein-metabolites. J Clin Biochem Nutr. 52:193–201.
  • Franke AA, Lai JF, Halm BM. 2014. Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake. Arch Biochem Biophys. 559:24–28.
  • Gardana C, Simonetti P, Berti C, Pietta PG. 2007. Evaluation of propolis polyphenols absorption in humans by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 21:3849–3854.
  • Gardana C, Canzi E, Simonetti P. 2009. The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers. J Nutr Biochem. 20:940–947.
  • Gardana C, Canzi E, Simonetti P. 2014. R(-)-O-desmethylangolensin is the main enantiomeric form of daidzein metabolite produced by human in vitro and in vivo. J Chromatogr B. 953:30–37.
  • Gu L, Laly M, Chang HC, Prior RL, Fang N, Ronis MJ, Badger TM. 2005. Isoflavone conjugates are underestimated in tissues using enzymatic hydrolysis. J Agric Food Chem. 53:6858–6863.
  • Hodis HN, Mack WJ, Kono N, Azen SP, Shoupe D, Hwang-Levne J, Petitti D, Whitefield-Maxwell L, Yan M, Franke AA, et al. 2011. Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Stroke. 42:3168–3175.
  • Hosoda K, Furuta T, Ishii K. 2011. Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of Kinako. Drug Metab Dispos. 39:1762–1767.
  • Koh E, Mitchell AE. 2011. Characterization of urinary isoflavone metabolites excreted after the consumption of soy flour or soybean paste using LC-(ESI)MS/MS. J Food Biochem. 35:1474–1485.
  • Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S; JPHC Study Group. 2007. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 116:2553–2562.
  • Lee SA, Shu XO, Li H, Yang G, Cai H, Wen W, Ji BT, Gao J, Gao YT, Zheng W. 2009. Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr. 89:1920–1926.
  • Legette LL, Prasain J, King J, Arabshahi A, Barnes S, Weaver CM. 2014. Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (Dietary versus intestinal production) in ovariectomized rats. J. Agric. Food Chem. 62:1294–1300.
  • Redmon JM, Shrestha B, Cerundolo R, Court MH. 2016. Soy isoflavone metabolism in cats compared with other species: urinary metabolite concentrations and glucuronidation by liver microsomes. Xenobiotica. 46:406–415.
  • Rice S, Mason HD, Whitehead SA. 2006. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol. 101:216–225.
  • Rimbach G, Saadatmandi CG, Frank J, Fuchs D, Wenzel U, Daniel H, Hall WL, Weinberg PD. 2008. Dietary isoflavones in prevention of cardiovascular disease – a molecular perspective. Food Chem Toxicol. 43:1308–1319.
  • Schwen RJ, Nguyen L, Jackson RL. 2012. Elucidation of the metabolic pathway of S-equol in rat, monkey and man. Food Chem Toxicol. 50:74–83.
  • Setchell KD, Cole SJ. 2006. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 136:2188–2193.
  • Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, et al. 2000. Bioanalytical method validation-a revisit with a decade of progress. Pharm Res. 17:1551–1557.
  • Shelnutt SR, Cimino CO, Wiggins PA, Badger TM. 2000. Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein. Cancer Epidemiol Biomarkers Prev. 9:413–419.
  • Shelnutt SR, Cimino CO, Wiggins PA, Ronis MJ, Badger TM. 2002. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr. 76:588–594.
  • Thomas BF, Zeisel SH, Busby MG, Hill JM, Mitchell RA, Scheffler NM, Brown SS, Bloeden LT, Dix KJ, Jeffcoat AR. 2001. Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B. 760:191–205.
  • Travis RC, Spencer EA, Allen NE, Appleby PN, Roddam AW, Overvad K, Johnsen NF, Olsen A, Kaaks R, Linseisen J, et al. 2009. Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 100:1817–1823.
  • Walsh KR, Haak SJ, Bohn T, Tian Q, Schwartz SJ, Failla ML. 2007. Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies. Am J Clin Nutr. 85:1050–1056.
  • Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wähälä K, Adlercreutz H. 1998. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after Ingestion of 60 g baked soybean powder (Kinako). J Nutr. 128:1710–1715.
  • Wong CK, Keung WM. 1997. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Biochem Biophys Res Commun. 233:579–583.
  • Xia Y, Chen M, Zhu P, Lu C, Fu G, Zhou X, Chen D, Wang H, Hang B, Wang S, et al. 2013. Urinary phytoestrogen levels related to idiopathic male infertility in Chinese men. Environ Int. 59:161–167.
  • Xiao Q, Park Y, Hollenbeck AR, Kitahara CM. 2014. Dietary flavonoid intake and thyroid cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev. 23:1102–1108.
  • Yang G, Shu XO, Jin F, Elasy T, Li HL, Li Q, Huang F, Zhang XL, Gao YT, Zheng W. 2004. Soyfood consumption and risk of glycosuria: a crosssectional study within the Shanghai Women’s Health Study. Eur J Clin Nutr. 58:615–620.
  • Zhang Y, Hendrich S, Murphy PA. 2003. Glucuronides are the main isoflavone metabolites in Women. J Nutr. 133:399–404.
  • Zubik L, Meydani M. 2003. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr. 77:1459–1465.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.